SS1(dsFv)-PE38 (SS1P)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SS1(dsFv)-PE38 (SS1P), covering 2014-11-14 to 2014-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days [Phase 1]